Table 2. Functional Outcome Per Implant Type for Metastatic Humerus (%).

Author, year

Implant

Follow-up (Months)

Patients

Outcome measure

Median score (Range)

Scotti, C. et al (2008)

EPR

30

40

MSTS

73.1a (69.9-76.3)

Cannon CP et al (2009)

EPR

24

67

MSTS

63a(40-83)

Piccioli A et al (2010)

EPR

IMN

8

26

57

MSTS

73a

79a

Raiss, P. et al (2010)

EPR

38

30

MSTS

19a(7-27)

Griffiths, D. et al (2011)

EPR

71

30

MSTS

72.3a(53.3- 100)

Choi ES et al (2016)

IMN

14.2

32

MSTS

27.7a(27.0-28.5)

Pruksakorn D et al (2015)

ERP

16

16

MSTS

33-77

Siegel, H.J. et al (2010)

ORIF

17.6

23

MSTS

94.6 a(86-99)

MSTS, musculoskeletal tumor society score; EPR, endoprosthesis; IMN, intramedullary nail; ORIF, open reduction internal fixation.

a Mean score.